Skip to main content

BKEMV

NDC 55513-180 · Amgen Inc

Generic nameeculizumab-aeeb
Dosage formINJECTION, SOLUTION, CONCENTRATE
RouteINTRAVENOUS
Active ingredient(s)ECULIZUMAB
Strength300 mg/30mL
Pharmacologic classComplement Inhibitor [EPC], Complement Inhibitors [MoA]
Marketing categoryBLA

Packages

55513-180-01 — 1 VIAL in 1 CARTON (55513-180-01) / 30 mL in 1 VIAL

Billed under HCPCS

Q5152 — Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg Medicare Part B payment limit (ASP + 6%): $41.16

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

25682-001 — ECULIZUMAB, 51759-208 — Eculizumab-aagh

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.